Integra Lifesciences recently received an FDA warning letter pertaining to quality systems issues at several facilities.

In a regulatory filing on Monday, Integra LifeSciences (IART) said that on December 19, 2024, a subsidiary received a warning letter from the ...

Investors in Integra LifeSciences Holdings Corporation IART need to pay close attention to the stock based on moves in the options market lately. That is because the March 21, 2025 $5 Callhad some of ...

BTIG analyst Ryan Zimmerman maintained a Hold rating on Integra Lifesciences (IART – Research Report) today. The company’s shares closed today ...

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their ...

Integra LifeSciences Holdings said a subsidiary received a warning letter from the Food and Drug Administration over issues identified during inspections at three company facilities. The medical ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

One company to watch right now is Integra LifeSciences (IART). IART is currently sporting a Zacks Rank of #2 (Buy) and an A for Value. Value investors also frequently use the P/S ratio.

Clearly, options traders are pricing in a big move for Integra LifeSciences shares, but what is the fundamental picture for the company? Currently, Integra LifeSciences is a Zacks Rank #2 (Buy ...